Katarina Ejeskär
Impact in
- Neurology top 5%
- Neuroblastoma Research and Treatments
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 5
- Cell death mechanisms and regulation 4
- Neurology 21
- Neuroblastoma Research and Treatments 21
- Co-authors
- Tommy Martinsson (15 shared papers)Per Kogner (10 shared papers)Frida Abel (10 shared papers)Susanne Fransson (9 shared papers)Cecilia Krona (5 shared papers)Helena Carén (5 shared papers)Hiroyuki Aburatani (1 shared paper)Jonas Abrahamsson (1 shared paper)
In The Last Decade
Katarina Ejeskär
35 papers receiving 585 citations
Peers
Comparison fields: 5 of 73
- Neurology 223
- Cancer Research 188
- Molecular Biology 400
- Oncology 125
- Genetics 32
Countries citing papers authored by Katarina Ejeskär
This map shows the geographic impact of Katarina Ejeskär's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katarina Ejeskär with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katarina Ejeskär more than expected).
Fields of papers citing papers by Katarina Ejeskär
This network shows the impact of papers produced by Katarina Ejeskär. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katarina Ejeskär. The network helps show where Katarina Ejeskär may publish in the future.
Co-authors
The 25 scholars most cited alongside Katarina Ejeskär, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 57 | |
| 2 | 1998 | 55 | |
| 3 | 2007 | 48 | |
| 4 | 2003 | 45 | |
| 5 | 1999 | 40 | |
| 6 | 2002 | 33 | |
| 7 | 2000 | 28 | |
| 8 | 2006 | 27 | |
| 9 | 2005 | 27 | |
| 10 | 2016 | 24 | |
| 11 | 2012 | 21 | |
| 12 | 2011 | 19 | |
| 13 | 1999 | 18 | |
| 14 | 2020 | 17 | |
| 15 | 2022 | 16 | |
| 16 | 2016 | 15 | |
| 17 | 2004 | 14 | |
| 18 | 2020 | 12 | |
| 19 | 2018 | 10 | |
| 20 | 2021 | 8 |
About Katarina Ejeskär
Katarina Ejeskär is a scholar working on Molecular Biology, Neurology, Cancer Research, Oncology and Epidemiology, having authored 35 papers that have together received 593 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (21 papers), Cancer, Hypoxia, and Metabolism (14 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Cell death mechanisms and regulation (4 papers), Neuroendocrine Tumor Research Advances (4 papers), Virus-based gene therapy research (3 papers), Cardiomyopathy and Myosin Studies (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Neurology (223 citations), Cancer Research (188 citations), Molecular Biology (400 citations), Oncology (125 citations) and Genetics (32 citations). Katarina Ejeskär has collaborated with scholars based in Sweden, Australia and Spain. Frequent co-authors include Tommy Martinsson, Per Kogner, Frida Abel, Susanne Fransson, Cecilia Krona, Helena Carén, Hiroyuki Aburatani, Jonas Abrahamsson, Panayiotis A. Ioannou and Rose‐Marie Sjöberg. Their work appears in journals such as British Journal of Cancer, BMC Cancer, International Journal of Molecular Medicine, Oncogene and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.